# Detection and Quantification of Atrial Fibrillation in High-risk Patients Using a Smartwatch Wearable (Apple Watch)

Study · id `cardio:ct-nct05686330` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05686330](<https://clinicaltrials.gov/study/NCT05686330>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05686330

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 436 participants.

## Technical summary

Registry record NCT05686330. Randomized; no masking; primary purpose diagnostic. Start 2022-11-16 (actual); primary completion 2025-07-17 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 436 participants (enrolled count; ClinicalTrials.gov record NCT05686330, source copy `cardio:ctgov-nct05686330-2025-09-16`, retrieved 2026-10-26)
- Started: 2022-11-16 (actual) (ClinicalTrials.gov record NCT05686330, source copy `cardio:ctgov-nct05686330-2025-09-16`, retrieved 2026-10-26)
- Primary completion: 2025-07-17 (actual) (ClinicalTrials.gov record NCT05686330, source copy `cardio:ctgov-nct05686330-2025-09-16`, retrieved 2026-10-26)
- Completion: 2025-07-17 (actual) (ClinicalTrials.gov record NCT05686330, source copy `cardio:ctgov-nct05686330-2025-09-16`, retrieved 2026-10-26)
- Countries: Netherlands (ClinicalTrials.gov record NCT05686330, source copy `cardio:ctgov-nct05686330-2025-09-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05686330-2025-09-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Detection and Quantification of Atrial Fibrillation in High-risk Patients Using a Smartwatch Wearable (Apple Watch)
- Acronym: EQUAL
- Condition: Atrial Fibrillation
- Intervention (Device): Apple Watch
- Lead sponsor: Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Enhanced Detection and Prompt Diagnosis of Atrial Fibrillation Using Apple Watch: A Randomized Controlled Trial (`cardio:pubmed-41569211`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 0e9f09b11473fcc9d5a60e1311867ed6873ac950d7f037c64a48a7f04b89c19c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
